EQT to acquire majority position to support the growth of CluePoints, a leading provider of AI-powered software solutions used for data interrogation and analytics in clinical trials

EQT Sweden

CluePoints is a cloud-based software platform for Risk-Based Quality Management ("RBQM") and data quality oversight in clinical trials, designed to enable safer and more efficient processes and improving data integrity and risk complianceAs scientific breakthroughs and advancements in technology and data are accelerating healthcare innovation, the markets for RBQM and data interrogation & analytics software are expected to experience strong growthIn this highly thematic investment at the intersection of pharma, software and AI, EQT will apply its expertise investing in healthcare and throughout the tech value-chain to help CluePoints cement its leading global positionSummit Partners, an investor in CluePoints since 2020, and Clinimetrics SA, a co-founder of CluePoints, will retain minority stakes with participation in this funding roundView original content:https://www.prnewswire.co.uk/news-releases/eqt-to-acquire-majority-position-to-support-the-growth-of-cluepoints-a-leading-provider-of-ai-powered-software-solutions-used-for-data-interrogation-and-analytics-in-clinical-trials-302170600.html